Furthermore, as CXCL2 could modulate cholesterol synthesis, which in turn affects neutrophil function, therefore combining high CXCL2 expression with statin treatment may synergistically inhibit HCC progression. The gene discussed is CXCL2; the disease is hepatocellular carcinoma.